Surgical management of tricuspid valve endocarditis in the current era: A review.

[1]  Sabit Kocabeyoglu,et al.  Long term results comparing mechanical and biological prostheses in the tricuspid valve position: which valve types are better--mechanical or biological prostheses? , 2014, Heart, lung & circulation.

[2]  R. Charnigo,et al.  The changing 'face' of endocarditis in Kentucky: an increase in tricuspid cases. , 2014, The American journal of medicine.

[3]  T. Wang,et al.  Characteristics and outcomes for right heart endocarditis: six-year cohort study. , 2014, Heart, lung & circulation.

[4]  Thoralf M Sundt,et al.  2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. , 2014, Circulation.

[5]  Thoralf M Sundt,et al.  2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. , 2014, Journal of the American College of Cardiology.

[6]  K. Peck,et al.  Clinical Features of Right-Sided Infective Endocarditis Occurring in Non-Drug Users , 2014, Journal of Korean medical science.

[7]  Kyung-Hwan Kim,et al.  Propensity score matching analysis of mechanical versus bioprosthetic tricuspid valve replacements. , 2014, The Annals of thoracic surgery.

[8]  M. Karck,et al.  Surgical treatment of infective endocarditis in active intravenous drug users: a justified procedure? , 2014, Journal of Cardiothoracic Surgery.

[9]  Sean M. O'Brien,et al.  Current outcomes for tricuspid valve infective endocarditis surgery in North America. , 2013, The Annals of thoracic surgery.

[10]  K. Akinosoglou,et al.  Native valve right sided infective endocarditis. , 2013, European journal of internal medicine.

[11]  B. Prendergast,et al.  The infective endocarditis team: recommendations from an international working group , 2013, Heart.

[12]  C. Chung,et al.  Mechanical Valve Replacement Versus Bioprosthetic Valve Replacement in the Tricuspid Valve Position , 2013, Journal of cardiac surgery.

[13]  Andrew Wang,et al.  SY.3.1 CLINICAL CHARACTERISTICS AND OUTCOME OF INFECTIVE ENDOCARDITIS INVOLVING IMPLANTABLE CARDIAC DEVICES , 2013 .

[14]  J. Gaughan,et al.  Surgical management of tricuspid valve endocarditis in systemically infected patients. , 2012, The Journal of heart valve disease.

[15]  K. Akinosoglou,et al.  Right-sided infective endocarditis: surgical management. , 2012, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[16]  S. Yun,et al.  Early surgery versus conventional treatment for infective endocarditis. , 2012, The New England journal of medicine.

[17]  Rosário Oliveira,et al.  Infective endocarditis in intravenous drug abusers: an update , 2012, European Journal of Clinical Microbiology & Infectious Diseases.

[18]  M. Hannan,et al.  Clinical characteristics and outcome of infective endocarditis involving implantable cardiac devices. , 2012, JAMA.

[19]  C. Young,et al.  What are the differences in outcomes between right-sided active infective endocarditis with and without left-sided infection? , 2012, Interactive cardiovascular and thoracic surgery.

[20]  B. Prendergast,et al.  Guidelines for the diagnosis and antibiotic treatment of endocarditis in adults: a report of the Working Party of the British Society for Antimicrobial Chemotherapy. , 2012, The Journal of antimicrobial chemotherapy.

[21]  Wayne Hall,et al.  Extent of illicit drug use and dependence, and their contribution to the global burden of disease , 2012, The Lancet.

[22]  D. Murdoch,et al.  Association between valvular surgery and mortality among patients with infective endocarditis complicated by heart failure. , 2011, JAMA.

[23]  Daniel R. Frisch,et al.  16-year trends in the infection burden for pacemakers and implantable cardioverter-defibrillators in the United States 1993 to 2008. , 2011, Journal of the American College of Cardiology.

[24]  S. Prabhakaran,et al.  Surgical management of endocarditis: the society of thoracic surgeons clinical practice guideline. , 2011, The Annals of thoracic surgery.

[25]  M. Abrahamowicz,et al.  Changing mortality in congenital heart disease. , 2010, Journal of the American College of Cardiology.

[26]  M. Caputo,et al.  Surgical treatment of tricuspid valve endocarditis: a single-centre experience , 2010, Perfusion.

[27]  K. Kamohara,et al.  Three surgical cases of isolated tricuspid valve infective endocarditis. , 2010, Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia.

[28]  Chang-qing Gao,et al.  [Surgical treatment of isolated right-sided infective endocarditis]. , 2010, Zhonghua wai ke za zhi [Chinese journal of surgery].

[29]  Walter R Wilson,et al.  Update on cardiovascular implantable electronic device infections and their management: a scientific statement from the American Heart Association. , 2010, Circulation.

[30]  Jimmy H. Chim,et al.  Mitral valve infective endocarditis: benefit of early operation and aggressive use of repair. , 2009, The Annals of thoracic surgery.

[31]  Andrew Wang,et al.  Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study. , 2009, Archives of internal medicine.

[32]  Eduardo Villacorta,et al.  Endocarditis derecha aislada en pacientes no adictos a drogas por vía parenteral , 2008 .

[33]  R. Lange,et al.  Tricuspid valve surgery: a thirty-year assessment of early and late outcome. , 2008, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[34]  Ernst Wolner,et al.  Midterm follow-up of tricuspid valve reconstruction due to active infective endocarditis. , 2007, The Annals of thoracic surgery.

[35]  Joanne E Brady,et al.  Nationwide increase in the number of hospitalizations for illicit injection drug use-related infective endocarditis. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[36]  Roland Hetzer,et al.  Surgical treatment of right-sided active infective endocarditis with or without involvement of the left heart: 20-year single center experience. , 2007, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[37]  David L Hayes,et al.  Management and outcome of permanent pacemaker and implantable cardioverter-defibrillator infections. , 2007, Journal of the American College of Cardiology.

[38]  Jeroen J. Bax,et al.  Mitral valve repair and replacement in endocarditis: a systematic review of literature. , 2007, The Annals of thoracic surgery.

[39]  杜昕,et al.  Infective endocarditis , 2007 .

[40]  Susan Armstrong,et al.  Midterm outcomes of tricuspid valve repair versus replacement for organic tricuspid disease. , 2006, The Annals of thoracic surgery.

[41]  P. Martín-Dávila,et al.  Analysis of mortality and risk factors associated with native valve endocarditis in drug users: the importance of vegetation size. , 2005, American heart journal.

[42]  Bartley P Griffith,et al.  A novel approach to tricuspid valve replacement: the upside down stentless aortic bioprosthesis. , 2005, The Annals of thoracic surgery.

[43]  K. Anstrom,et al.  Staphylococcus aureus endocarditis: a consequence of medical progress. , 2005, JAMA.

[44]  M. Enriquez-Sarano,et al.  Comparison of clinical and morphological characteristics of Staphylococcus aureus endocarditis with endocarditis caused by other pathogens , 2005, Heart.

[45]  P. Heidenreich,et al.  Increasing rates of cardiac device infections among Medicare beneficiaries: 1990-1999. , 2004, American heart journal.

[46]  R. Moss,et al.  Injection drug use and right sided endocarditis , 2003, Heart.

[47]  J. Miro,et al.  Infective endocarditis and cardiac surgery in intravenous drug abusers and HIV-1 infected patients. , 2003, Cardiology clinics.

[48]  F. Alla,et al.  Changing profile of infective endocarditis: results of a 1-year survey in France. , 2002, JAMA.

[49]  J. Miro,et al.  Infective endocarditis in intravenous drug abusers and HIV-1 infected patients. , 2002, Infectious disease clinics of North America.

[50]  Miyagishima Rt,et al.  Tricuspid valve replacement using a cryopreserved mitral homograft. Surgical technique and initial results. , 2000 .

[51]  J. Frontera,et al.  Right-side endocarditis in injection drug users: review of proposed mechanisms of pathogenesis. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[52]  G. Primo,et al.  Tricuspid valve replacement: postoperative and long-term results. , 1995, The Journal of thoracic and cardiovascular surgery.

[53]  A Arbulu,et al.  Surgical treatment of intractable right-sided infective endocarditis in drug addicts: 25 years experience. , 1993, The Journal of heart valve disease.

[54]  T. David.  Replacement of Chordae Tendineae with Expanded Polytetrafluoroethylene Sutures , 1989, Journal of cardiac surgery.

[55]  A. Carpentier,et al.  Cardiac valve surgery--the "French correction". , 1983, The Journal of thoracic and cardiovascular surgery.

[56]  A. Arbulu,et al.  Tricuspid valvulectomy without prosthetic replacement. Ten years of clinical experience. , 1981, The Journal of thoracic and cardiovascular surgery.

[57]  N. W. Thomas,et al.  Hemodynamic consequences of total removal of the tricuspid valve without prosthetic replacement. , 1975, The American journal of cardiology.

[58]  A. Arbulu.  Tricuspid valvulectomy without prosthetic replacement. , 1973, AORN journal.

[59]  J. Kay,et al.  Surgical Treatment of Tricuspid Insufficiency , 1965, Annals of surgery.

[60]  A. Haverich,et al.  Surgical treatment for isolated tricuspid valve endocarditis- long-term follow-up at a single institution. , 2013, Circulation journal : official journal of the Japanese Circulation Society.

[61]  Sean M. O'Brien,et al.  Outcomes for endocarditis surgery in North America: a simplified risk scoring system. , 2011, The Journal of thoracic and cardiovascular surgery.

[62]  R. Margey,et al.  Contemporary management of and outcomes from cardiac device related infections. , 2010, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[63]  M. Pasque,et al.  Outcomes of tricuspid valve repair and replacement: a propensity analysis. , 2009, The Annals of thoracic surgery.

[64]  P. Seferovic.  The Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC) , 2009 .

[65]  David L Hayes,et al.  Infective endocarditis complicating permanent pacemaker and implantable cardioverter-defibrillator infection. , 2008, Mayo Clinic proceedings.

[66]  E. Villacorta,et al.  Isolated right-sided valvular endocarditis in non-intravenous drug users. , 2008, Revista espanola de cardiologia.

[67]  Nader Moazami,et al.  Long-term outcomes in valve replacement surgery for infective endocarditis. , 2007, The Annals of thoracic surgery.

[68]  A. Della Corte,et al.  Infective endocarditis in intravenous drug abusers: patterns of presentation and long-term outcomes of surgical treatment. , 2006, The Journal of heart valve disease.

[69]  M E Ellis,et al.  Fungal endocarditis: evidence in the world literature, 1965-1995. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.